Concepedia

Present Profiles of Novel Anticoagulant Use in Japanese Patients with Atrial Fibrillation: Insights from the Rivaroxaban Postmarketing Surveillance Registry

Satoshi Ogawa, Takanori Ikeda, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, Kazuma Iekushi, Satoshi Yamanaka, Takashi Yamada,

Journal of Stroke and Cerebrovascular Diseases · 2014 · 25 citations · 9 references

DOI

Concepts

References

9

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Philip A. Wolf, Robert D. Abbott, W B Kannel · Stroke · 1991 · 7.5K citations

, , +14

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text

, , +12

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

Dagmar Kubitza, Michael Becka, Georg Wensing et al. · European Journal of Clinical Pharmacology · 2005 · 648 citations

, , +5

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi et al. · Circulation Journal · 2012 · 638 citations · Full text

, , +14